Jacobs Levy Equity Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-45,602
| Closed | -$23.7K | – | 1178 |
|
|
2024
Q4 | $23.7K | Sell |
45,602
-112,070
| -71% | -$58.3K | ﹤0.01% | 923 |
|
|
2024
Q3 | $511K | Buy |
157,672
+78,779
| +100% | +$255K | ﹤0.01% | 829 |
|
|
2024
Q2 | $237K | Sell |
78,893
-47,023
| -37% | -$141K | ﹤0.01% | 908 |
|
|
2024
Q1 | $586K | Sell |
125,916
-87,704
| -41% | -$408K | ﹤0.01% | 802 |
|
|
2023
Q4 | $884K | Buy |
213,620
+87,774
| +70% | +$363K | ﹤0.01% | 743 |
|
|
2023
Q3 | $378K | Buy |
+125,846
| New | +$378K | ﹤0.01% | 849 |
|